CIK 0001728328
- Emerging growth company
Mentari Therapeutics, Inc.
Sign in to watch- Ticker
- MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 981428279
- Phone
- +1 781-887-5080
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- InMed Pharmaceuticals Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CFO bought 5,000 shares at $1.09 ($5,439)
- 4 Open-market buy SVP, GM of BayMedica LLC bought 8,500 shares at $1.26 ($10,710)
- 4 Open-market buy SVP, GM of BayMedica LLC bought 8,093 shares at $1.33 ($10,736)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy SVP, GM of BayMedica LLC bought 5,000 shares at $1.37 ($6,845)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President & CEO bought 8,800 shares at $1.73 ($15,224)
Page 7 of 8 · 160 filings